Patients Mutual Assistance v. Cir

CourtCourt of Appeals for the Ninth Circuit
DecidedApril 22, 2021
Docket19-73078
StatusPublished

This text of Patients Mutual Assistance v. Cir (Patients Mutual Assistance v. Cir) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Patients Mutual Assistance v. Cir, (9th Cir. 2021).

Opinion

FOR PUBLICATION

UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

PATIENTS MUTUAL ASSISTANCE No. 19-73078 COLLECTIVE CORPORATION, DBA Harborside Health Center, Tax Ct. Nos. Petitioner-Appellant, 29212-11 30851-12 v. 14776-14

COMMISSIONER OF INTERNAL REVENUE, OPINION Respondent-Appellee.

Appeal from a Decision of the United States Tax Court

Argued and Submitted February 9, 2021 San Francisco, California

Filed April 22, 2021

Before: Andrew D. Hurwitz and Daniel A. Bress, Circuit Judges, and Clifton L. Corker, * District Judge.

Opinion by Judge Bress

* The Honorable Clifton L. Corker, United States District Judge for the Eastern District of Tennessee, sitting by designation. 2 PATIENTS MUTUAL ASSISTANCE COLLECTIVE V. CIR

SUMMARY **

Tax

The panel affirmed the Tax Court’s decision on a petition for redetermination of federal income tax deficiencies that turned on whether a cannabis dispensary that purchases the marijuana it resells and values its inventory using the cost method of accounting must account for its inventory cost in accordance with Treasury Regulation § 1.471-3(b).

Patients Mutual Assistance Collective Corporation, dba Harborside Health Center (“Harborside”), is one of the largest marijuana dispensaries in the country. For the years at issue, Harborside was a not-for-profit corporation and medicinal cannabis collective that operated a retail cannabis dispensary under California state law. Harborside claimed tens of millions of dollars in exclusions. The Commissioner of Internal Revenue disallowed nearly all of them, then issued notices of deficiency. On a petition for redetermination of the deficiencies, the Tax Court ruled in favor of the Commissioner, and this appeal followed.

Most corporations can claim deductions for “ordinary and necessary expenses” that are “paid or incurred during the taxable year in carrying on any trade or business.” I.R.C. § 162(a). However, otherwise allowed deductions are not available to taxpayers who engage in certain activities that Congress regards as unlawful, I.R.C. § 280E, including trafficking in controlled substances like marijuana. The panel first declined to consider the constitutional claim, not

** This summary constitutes no part of the opinion of the court. It has been prepared by court staff for the convenience of the reader. PATIENTS MUTUAL ASSISTANCE COLLECTIVE V. CIR 3

raised in the Tax Court, that § 280E violates the Sixteenth Amendment.

Harborside next argued that some of its expenditures, even if they cannot be deducted under § 280E, can be excluded from income as part of its inventory cost under general inventory tax accounting rules. Rejecting Harborside’s arguments that would have made more of its costs excludible for tax purposes, the panel held that the Tax Court did not err in concluding that Harborside’s inventory cost is determined by Treas. Reg. § 1.471-3(b), which applies to a purchaser and reseller of the products it sells.

The panel declined to consider Harborside’s argument, not raised before the Tax Court, that the Tax Court should have allowed at least some of Harborside’s claimed exclusions as “necessary charges incurred in acquiring possession of the goods” under Treas. Reg. § 1.471-3(b). The panel therefore expressed no opinion on whether any of Harborside’s claimed exclusions may have been properly regarded as inventory costs under § 1.471-3(b), nor did it address arguments made by amici curiae that Harborside did not advance on appeal.

COUNSEL

James B. Mann (argued), Brooklyn, New York, for Petitioner-Appellant.

Nathaniel S. Pollock (argued), Francesca Ugolini, and Michael J. Haungs, Attorneys; T. Joshua Wu, Deputy Assistant Attorney General; Richard E. Zuckerman, Principal Deputy Assistant Attorney General; Tax Division, United States Department of Justice, Washington, D.C.; for Respondent-Appellee. 4 PATIENTS MUTUAL ASSISTANCE COLLECTIVE V. CIR

Charles C. Sipos and Lauren Watts Staniar, Perkins Coie LLP, Seattle, Washington; Barak Cohen and Tre A. Holloway, Perkins Coie LLP, Washington, D.C.; for Amicus Curiae National Cannabis Industry Association.

Jennifer E. Benda, Hall Estill Hardwick Gable Golden & Nelson P.C., Denver, Colorado, for Amici Curiae Marijuana Industry Group and Cannabis Trade Federation Action.

OPINION

BRESS, Circuit Judge:

On its face, this tax case presents the technical issue whether a cannabis dispensary that purchases the marijuana it resells and that values its inventory using the cost method must account for its inventory cost in accordance with section 1.471-3(b) of the Treasury Regulations. But at its core, this dispute reflects the latest attempt by a medical marijuana retailer to ameliorate the significant tax consequences Congress has prescribed for businesses that Congress regards as trafficking in controlled substances. Under federal law, those prohibited substances include marijuana, even though some states have more recently legalized its sale. This disharmony between federal and state law produces the multi-million-dollar tax controversy before us. Ultimately, we hold that the taxpayer’s arguments either are without merit or were not preserved for our review. We therefore affirm the Tax Court.

I

The taxpayer is Patients Mutual Assistance Collective Corporation, one of the largest marijuana dispensaries in the United States. It is a C corporation under federal tax law that PATIENTS MUTUAL ASSISTANCE COLLECTIVE V. CIR 5

does business as Harborside Health Center. We refer to it as “Harborside.” This appeal concerns Harborside’s corporate income tax liabilities for its tax years ending July 31, 2007 through July 31, 2012. To understand Harborside’s arguments, it is necessary to have some understanding of its business.

Harborside operates a retail cannabis dispensary. For the years at issue, Harborside was a not-for-profit corporation and medicinal cannabis collective operating under California laws governing medical marijuana operations. See Cal. Health & Safety Code §§ 11362.765(a), 11362.768. Consistent with California law, Harborside sold products only to individuals who possessed a physician’s written recommendation for medical marijuana. See id. § 11362.5(d). Prospective members also had to sign a cultivation agreement permitting other Harborside members to grow marijuana on their behalf as part of the Harborside collective.

Harborside sold several categories of products, including “buds,” or cannabis flowers. Harborside purchased buds from its patients-growers and did not grow any itself. Would-be sellers brought buds to Harborside’s purchasing office, where a Harborside employee would inspect and test the buds for quality. If the buds were acceptable, the employee negotiated a purchase price. Once Harborside purchased the buds, it stored them in a secure vault and sent a sample for third-party laboratory testing. If the results were satisfactory, employees would reinspect, trim, weigh, package, and label the buds in preparation for resale.

Harborside also purchased from nurseries marijuana “clones,” i.e., “cuttings from a female cannabis plant that can be transplanted and used to cultivate marijuana.” After acquiring clones, Harborside stored, cared for, and 6 PATIENTS MUTUAL ASSISTANCE COLLECTIVE V. CIR

repackaged them before sale. Additionally, Harborside purchased and resold other marijuana-containing products, such as extracts and oils, which it purchased from other marijuana collectives, as well as non-marijuana products such as branded shirts and various marijuana-related paraphernalia. As a C corporation, Harborside pays corporate income tax on its “taxable income.” I.R.C. § 11(a); see also id. § 1361(a)(2) (defining “C corporation”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thor Power Tool Co. v. Commissioner
439 U.S. 522 (Supreme Court, 1979)
United States v. Shawn Gementera
379 F.3d 596 (Ninth Circuit, 2004)
Sparkman v. Commissioner
509 F.3d 1149 (Ninth Circuit, 2007)
Estate of Gertrude Saunders v. Cir
745 F.3d 953 (Ninth Circuit, 2014)
Olive v. Commissioner
792 F.3d 1146 (Ninth Circuit, 2015)
Knudsen v. Commissioner
793 F.3d 1030 (Ninth Circuit, 2015)
Canna Care, Inc. v. Commissioner
694 F. App'x 570 (Ninth Circuit, 2017)
Alpenglow Botanicals, LLC v. United States
894 F.3d 1187 (Tenth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Patients Mutual Assistance v. Cir, Counsel Stack Legal Research, https://law.counselstack.com/opinion/patients-mutual-assistance-v-cir-ca9-2021.